Iodinated Contrast Media Induced Hyperthyroidism

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

January 2, 2015

Primary Completion Date

February 20, 2020

Study Completion Date

February 20, 2020

Conditions
Hyperthyroidism/ThyrotoxicosisHyperthyroidism; GoiterIodine Induced ThyrotoxicosisContrast Media Adverse ReactionThyrotoxicosis of Other Specified Origin
Interventions
PROCEDURE

Administration of iodinated contrast media

Each patient was exposed on iodinated contrast medium administered during computed tomography, coronary angiography or transcatheter aortic valve implantation.

DRUG

Prophylactic administration of antithyroid drugs before iodinated contrast media exposure

13 patients received thiamazole with (6 patients) or without (7 patients) sodium perchlorate, one day prior to iodinated contrast medium (ICM) and for at least 14 days after for thiamazole (20-40 mg/daily) and 10 days after for sodium perchlorate (900 mg/daily).

All Listed Sponsors
collaborator

National Institute of Cardiology, Warsaw, Poland

OTHER

lead

Medical University of Warsaw

OTHER

NCT04304794 - Iodinated Contrast Media Induced Hyperthyroidism | Biotech Hunter | Biotech Hunter